Author | Bernardo L. Rapoport, MD | OncLive

Author | Bernardo L. Rapoport, MD

Articles

Dr. Rapoport on Rolapitant for the Prevention of CINV

July 07, 2014

Video

Bernardo L. Rapoport, MD, chief medical oncologist, The Medical Oncology Center of Rosebank, Johannesburg, South Africa, discusses the utility of rolapitant for preventing chemotherapy-induced nausea and vomiting (CINV).

x